Inotuzumab Ozogamicin in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) with or without Blinatumomab vs. Standard Intensive Chemotherapy (hyper-CVAD) as Frontline Therapy for Older Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: a Propensity Score Analysis

BACKGROUND: The outcome of older patients with newly diagnosed Philadelphia chromosome (Ph)-negative acute lymphoblastic leukemia (ALL) is poor. The combination of targeted therapy with low-intensity chemotherapy was safe and effective. The aim of the analysis is to compare outcome of patients treat...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cancer
Prif Awduron: Jabbour, Elias, Sasaki, Koji, Ravandi, Farhad, Short, Nicholas J., Garcia-Manero, Guillermo, Daver, Naval, Kadia, Tapan, Konopleva, Marina, Jain, Nitin, Cortes, Jorge, Issa, Ghayas C., Jacob, Jovitta, Kwari, Monica, Thompson, Philip, Garris, Rebecca, Pemmaraju, Naveen, Yilmaz, Musa, O’Brien, Susan, Kantarjian, Hagop
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2019
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6625850/
https://ncbi.nlm.nih.gov/pubmed/30985931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.32139
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg